Assessing systemic disease risk in a dental setting: A Public health perspective

Dental Clinics of North America

Volumn 56, Issue 4, 2012, Pages 863-874

  Greenberg, Barbara L ^a   Glick, Michael ^b  

^a RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Coronary heart disease; Diabetes; Disease risk screening; Hypertension; Systemic disease risk

Indexed keywords

CORONARY ARTERY DISEASE; DENTAL PROCEDURE; DIABETES MELLITUS; EARLY DIAGNOSIS; HUMAN; HYPERTENSION; MASS SCREENING; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT;

CORONARY DISEASE; DENTAL CARE; DIABETES MELLITUS; EARLY DIAGNOSIS; HUMANS; HYPERTENSION; MASS SCREENING; PUBLIC HEALTH; RISK ASSESSMENT;

EID: 84866629551     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2012.07.011     Document Type: Review

References (83)

1. Northridge M.E., Glick M., Metcalf S.S., et al. Public health support for the health home model. Am J Public Health 2011, 101(11):1818-1820.
2. Centers for Disease Control. Health, United States, 2010 with special feature on death and dying. Trend tables, table 93. Dental visits in the past year by selected characteristics: United States, selected years 1997-2009. Available at: Accessed April 19, 2012. http://www.cdc.gov/nchs/data/hus/hus10.pdf.
3. Glick M., Greenberg B.L. The potential role of dentists in identifying patients' risk of experiencing coronary heart disease events. J Am Dent Assoc 2005, 136:1541-1546.
4. Pollack H.A., Metsch L.R., Abel S. Dental examinations as an untapped opportunity to provide HIV testing for high-risk individuals. Am J Public Health 2010, 100:88-89.
5. Saremi A., Nelson R.G., Tulloch-Reid M., et al. Periodontal disease and mortality in type 2 diabetes. Diabetes Care 2005, 28:27-32.
6. Taylor G.W., Borgnakke W.S. Periodontal disease: associations with diabetes, glycemic control and complications. Oral Dis 2008, 14:191-203.
7. Tsai C., Hayes C., Taylor G.W. Glycemic control of type-2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 2002, 30:182-192.
8. Lamster I.B., Lalla E., Borgnakke W.S., et al. The relationship between oral health and diabetes mellitus. J Am Dent Assoc 2008, 139(Suppl):19S-24S.
9. Ray K.K., Seshasa S.R., Wijesuriya S., et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomized controlled trials. Lancet 2012, 373:1765-1772.
10. Lalla E., Cheng B., Lal S., et al. Periodontal changes in children and adolescents with diabetes: a case-control study. Diabetes Care 2006, 29:295-299.
11. Morita I., Inagak K., Nakamura F., et al. Relationship between periodontal status and levels of glycated hemoglobin. J Dent Res 2012, 9(2):161-166.
12. Mattila K.J., Valle M.S., Nieminen M.S., et al. Dental infections and coronary atherosclerosis. Atherosclerosis 1993, 103:205-211.
13. Mattila K.J., Valtonen V.V., Nieminen M., et al. Dental infections and the risk of new coronary events: prospective study of patients with documented coronary artery disease. Clin Infect Dis 1995, 20:588-592.
14. Beck J.D., Slade G., Offenbacher S. Oral disease, cardiovascular disease, and systemic inflammation. Periodontol 2000, 23:110-120.
15. Southerland J.H., Moss K., Taylor G.W., et al. Periodontitis and diabetes associations with measures of atherosclerosis and CHD. Atherosclerosis 2012, 222:196-201.
16. Lockhart P.B., Bolger A.F., Papapanou P.N., et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?. Circulation 2012, 125:2520-2544.
17. American Heart Association Writing Group Heart disease and stroke statistics-2009 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:e21-e181.
18. Centers for Disease Control and Prevention (CDC). National Diabetes Fact Sheet, 2011. Available at: Accessed April 19, 2012. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.
19. Centers for Disease Control and Prevention Prevalence of coronary heart disease-United States, 2006-2010. MMWR Morb Mortal Wkly Rep 2012, 60(40):1377-1381.
20. Mozumdar A., Liguori G. Persistent increase of prevalence of metabolic syndrome among US adults: NHANES III to NHANES 1999-2006. Diabetes Care 2011, 34:216-219.
21. Cowie C.C., Rust K.F., Ford E.S., et al. Full accounting of diabetes care and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009, 32:287-294.
22. Ayanian J.Z., Zaslavsky A.M., Weissman J.S., et al. Undiagnosed hypertension and hypercholesterolemia among uninsured and insured adults in the Third National Health and Nutrition Examination Survey. Am J Public Health 2003, 93:2051-2054.
23. Centers for Disease Control and Prevention Vital signs: prevalence, treatment and control of hypertension-United States, 1999-2002 and 2005-2008. MMWR Morb Mortal Wkly Rep 2011, Available at:, Accessed April 12, 2012. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm60e0201a1.htm%3Fs_cid=mm60e0201a1_e%26source=govdelivery.
24. Centers for Disease Control and Prevention Vital Signs: prevalence, treatment and control of high levels of low-density lipoprotein cholesterol- United States, 1999-2002 and 2005-2008. MMWR Morb Mortal Wkly Rep 2011, Available at:, Accessed April 12, 2012. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6004a5.htm.
25. Boyle J.P., Thompson T.J., Gregg E.W., et al. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality and prediabetes prevalence. Popul Health Metr 2010, 8:29.
26. Centers for Disease Control and Prevention. Division of News and Electronic Media. Number of Americans with diabetes rises to nearly 26 million. More than a third of adults estimated to have diabetes. 2011. Available at: Accessed January 27, 2011. http://www.cdc.gov/media/releases/2011/p0126_diabetes.html.
27. Sox HC, Berwick DM, Berg AO, et al. U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd edition. U.S. Department of Health and Human Services, Office of Public Health and Science, Office of Disease Prevention and Health Promotion. Available at: Accessed April 24, 2012. http://odphp.osophs.dhhs.gov/pubs/guidecps/PDF/Frontmtr.PDF.
28. He J., Whelton P.K., Appel L.J., et al. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000, 35:544-549.
29. He J., Ogden L.C., Vupputuri S., et al. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. J Am Med Assoc 1999, 282:2027-2034.
30. Whelton S.P., Hyre A., Pedersen B., et al. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens 2005, 23:475-483.
31. He J., Gu D., Wu X., et al. Effect of soybean protein on blood pressure: a randomized controlled trial. Ann Intern Med 2005, 143:1-9.
32. Puglisi M.J., Vaishnav U., Shrestha S., et al. Raisins and additional walking have distinct effects on plasma lipids and inflammatory cytokines. Lipids Health Dis 2008, 16:7-14.
33. Bazzano L.A., He J., Ogden L.G., et al. Dietary fiber intake and reduced risk of coronary heart disease in US men and women. Arch Intern Med 2003, 163:1897-1904.
34. Bazzano L.A., He J., Ogden L.G., et al. Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic follow-up study. Am J Clin Nutr 2002, 76:93-99.
35. Li G., Zhang P., Wong J., et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing diabetes prevention study: a 20-year follow-up study. Lancet 2008, 371:1783-1789.
36. D'Agostino R.B., Grundy S., Sullivan L.M., et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic group investigation. J Am Med Assoc 2001, 286:180-187.
37. Menotti A., Lanti M., Puddu P.E., et al. Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for Europe coronary risk chart. Heart 2000, 84:238-244.
38. Liao Y., McGee D.L., Cooper R.S., et al. How generalizable are coronary risk prediction models? Comparison of Framingham and two nations' cohorts. Am Heart J 1999, 137:837-844.
39. Lee D.C., Sui X., Church T.S., et al. Changes in fitness and fatness on the development of cardiovascular disease and risk factors. J Am Coll Cardiol 2012, 59:665-672.
40. Balducci S., Zamusa S., Nicolucci A., et al. Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus. Arch Intern Med 2010, 170:1794-1803.
41. Curran A.E., Caplan D.J., Lee J.Y., et al. Dentists' attitudes about their role in addressing obesity in patients. A national survey. J Am Dent Assoc 2010, 14:1307-1316.
42. U.S.Preventive Services Task Force Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009, 151(7):474-482.
43. Wang T.J., Gona P., Larson M.G., et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006, 355:2631-2639.
44. Greenland P., Alpert J.S., Beller G.A., et al. 2010 ACCF/AHA Guidelines for assessment of cardiovascular risk in asymptomatic adults. J Am Coll Cardiol 2010, 56. 10.1016/jacc2010.09.002.
45. Saudek C.D., Herman W.H., Sacks D.B., et al. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008, 93:2447-2453.
46. Nathan D.M., Kuenen J., Borg R., et al. A1c-Derived average glucose study group. Translating the A1c assay into estimated average glucose values. Diabetes Care 2008, 31:1473-1478.
47. Lu Z.X., Walker K.Z., O'Dea K., et al. A1c screening and diagnosis of type 2 diabetes in routine clinical practice. Diabetes Care 2010, 33:817-819.
48. Selvin E., Steffes M.W., Zhu H., et al. Glycated hemoglobin, diabetes and cardiovascular risk in nondiabetic adults. N Engl J Med 2010, 362:800-811. 15.
49. Cheng P., Neugaard B., Foulis P., et al. Hemoglobin A1c as a predictor of incident diabetes. Diabetes Care 2011, 34:610-615.
50. Department of Health and Human Services. Proposed objectives to Healthy People 2020. 2009. Available at: Accessed January 24, 2011. http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx%3Ftopicid=32.
51. Lloyd-Jones D.M., Hong Y., Labarthe D., et al. Defining and setting national goals for cardiovascular health promotion and disease reduction. Circulation 2010, 121:586-613.
52. Bambs C., Kip K.E., Dinga A., et al. Low prevalence of " ideal cardiovascular health" in a community-based population. The heart strategies concentrating on risk evaluation (Heart SCORE) study. Circulation 2011, 123:850-857.
53. Khot U.N., Khot M.B., Bajzer C.T., et al. Prevalence of conventional risk factors in patients with coronary heart disease. J Am Med Assoc 2003, 290:898-904.
54. Greenland P., Knoll M.D., Stamler J., et al. Major risk factor as antecedents of fatal and nonfatal coronary heart disease events. J Am Med Assoc 2003, 290:891-897.
55. Magnus P., Beaglehole R. The real contribution of the major risk factors to the coronary epidemics: time to end the " only 50%" myth. Arch Intern Med 2001, 161:2657-2660.
56. Ridker P.M., Brown N.J., Vaughan D.E., et al. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004, 109(25 Suppl 1):IV6-IV19.
57. Ridker P.M., Rifai M., Rose I., et al. Comparison of C-reactive protein and low density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347:1557-1565.
58. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-1397.
59. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics. Circulation 2011, 123:e18-e209. http://dx.doi.org/10.1161CIR.0b013e3182009701.
60. Yang Q., Cogswell M.E., Flanders W.D., et al. Trends in cardiovascular health metrics and associations with all cause CVD mortality among US adults. J Am Med Assoc 2012, 307(12). 10.1001/jama.2012.339.
61. Berry J.D., Dyer A.D., Cai X., et al. Lifetime risks of cardiovascular disease. N Engl J Med 2012, 366:321-329.
62. Allen N., Berry J.D., Ning H., et al. Impact of blood pressure and blood pressure change during middle age on the remaining lifetime risk for cardiovascular disease. Circulation 2012, 125:37-44.
63. Chatterjee R., Narayan K.M., Lipscomb J., et al. Screening adults for pre-diabetes and diabetes may be cost saving. Targeted screening is likely to be even more cost effective. Diabetes Care 2010, 33:1484-1490.
64. The Diabetes Intervention Research Group The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention. An intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 2012, 35:723-730.
65. Greenberg B.L., Glick M., Goodchild J., et al. Screening for cardiovascular risk factors in a dental setting. J Am Dent Assoc 2007, 138(6):798-804.
66. Jontell M., Glick M. Oral health care professionals' identification of cardiovascular disease risk among patients in private dental offices in Sweden. J Am Dent Assoc 2009, 140:1385-1391.
67. Lalla E., Kunzel C., Burkett S., et al. Identification of unrecognized diabetes and prediabetes in a dental setting. J Dent Res 2011, 90:855-860.
68. Perkins M.B., Jensen P.S., Jaccard J., et al. Applying theory-driven approaches to understanding and modifying clinicians' behavior. What do we know?. Psychiatr Serv 2007, 58:342-348.
69. Limbert C., Lamb R. Doctors' use of clinical guidelines: two applications of Theory of Planned Behaviour. Psychol Health Med 2002, 7:301-310.
70. Walker A.E., Grimshaw J.M., Armstrong E.M. Salient beliefs and intension to prescribe antibiotics for patients with a sore throat. Br J Health Psychol 2001, 6:347-360.
71. Edwards H.E., Nash R.E., Najman J.M., et al. Determinants of nurses' intention to administer opioids for pain relief. Nurs Health Sci 2001, 3:149-159.
72. Walker A., Watson M., Grimshaw J., et al. Applying the theory of planned behavior to pharmacists' beliefs and intentions about the treatment of vaginal candidiasis with non-prescription medication. Fam Pract 2004, 21:670-676.
73. Farris K.B., Schopflocher D.P. Between intention and behavior: an application of community pharmacies' assessment of pharmaceutical care. Soc Sci Med 1999, 49:55-66.
74. Meissen G.J., Mason W.C., Gleason D.F. Understanding the attitudes and intentions of future professional toward self help. Am J Community Psychol 1991, 19:699-714.
75. Greenberg B., Glick M., Frantsve J., et al. Attitudes on screening for medical conditions by oral health care professionals. J Am Dent Assoc 2010, 141:52-62.
76. Forbes K., Murray Thomson W., Kunzel C., et al. Management of patients with diabetes by general dentists in New Zealand. J Periodontol 2008, 79:1401-1408.
77. Greenberg B.L., Kantor M.L., Jiang S., et al. Physicians' attitudes about medical screening in a dental setting. J Dent Res 2010, 89(Spec Iss B):4931.
78. Greenberg B.L., Kantor M.L., Jiang S.S., et al. Patients' attitudes toward screening for medical conditions in a dental setting. J Public Health Dent 2012, 72(1):28-35.
79. Sheridan S.L., Viera A.J., Krantz M.J., et al. The effect of giving global coronary risk information to adults. Arch Intern Med 2010, 170:230-239.
80. Sutherland D., Hayter M. Structured review: evaluating the effectiveness of nurse case managers in improving health outcomes in three major chronic diseases. J Clin Nurs 2009, 18:2978-2992.
81. Dietrich A.J., Tobin J.N., Cassells A., et al. Telephone care management to improve cancer screening among low-income women. Ann Intern Med 2006, 144:563-571.
82. Glick M. A home away from home. J Am Dent Assoc 2009, 140:140-142.
83. Glick M. One-stop shopping. J Am Dent Assoc 2007, 138(3):282-283.